Ajooni Biotech Limited — allotment of 9000000 securities pursuant to Preferential Issue at its meeting held on August 12, 2026

• Ajooni Biotech Limited has informed the Exchange regarding allotment of 9000000 securities pursuant to Preferential Issue at its meeting held on August 12, 2026
• Filed with NSE on 2026-08-12 under the category "Allotment of Securities". Classified from that category alone — no model and no PDF, because NSE has no category for losing an order or reducing capacity.

The company creates brand new shares and sells them to one chosen buyer — often a big investor or a promoter. Nobody else gets to buy. Because more shares now exist, your slice of the company gets smaller.

ExampleA company with 100 shares issues 12 new ones to an investor. You still hold what you held, but it is now a smaller fraction of the business.

Not automatically bad. The company gets cash, and a respected investor buying in is a vote of confidence. It depends on who bought and why.

About this kind of filing — not a reading of this one.